32nd week of 2020 patent applcation highlights part 9 |
Patent application number | Title | Published |
20200246324 | PHARMACEUTICAL COMPOSITIONS | 2020-08-06 |
20200246325 | METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS | 2020-08-06 |
20200246326 | METHODS FOR SOLID TUMOR TREATMENT | 2020-08-06 |
20200246327 | QUINOLINE AMIDES AND METHODS OF USING SAME | 2020-08-06 |
20200246328 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | 2020-08-06 |
20200246329 | NEURONAL MODULATION | 2020-08-06 |
20200246330 | ANTI-INFLAMMATORY, ANTI-CANCER, AND ANTI-ANGIOGENIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF MAKING AND USING THEREOF | 2020-08-06 |
20200246331 | Pharmaceutical combinations and their use | 2020-08-06 |
20200246332 | CARBOSTYRIL DERIVATIVES AND MOOD STABILIZERS FOR TREATING MOOD DISORDERS | 2020-08-06 |
20200246333 | METHODS FOR PRODUCING ARIPIPRAZOLE SUSPENSION AND FREEZE-DRIED FORMULATION | 2020-08-06 |
20200246334 | VIGOR ENHANCEMENT VIA ADMINISTRATION OF PYRIMIDINE DERIVATIVES | 2020-08-06 |
20200246335 | SLEEP IMPROVING AGENT | 2020-08-06 |
20200246336 | DRY EYE TREATMENTS | 2020-08-06 |
20200246337 | ANTAGONIST OF THE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) FOR USE IN THE TREATMENT OR THE PREVENTION OF SKELETAL DISORDERS LINKED WITH ABNORMAL ACTIVATION OF FGFR3 | 2020-08-06 |
20200246338 | COMBINATION THERAPY | 2020-08-06 |
20200246339 | NEW SALT OF N-(2,6-DIETHYLPHENYL)-8-({4-[4-(DIMETHYLAMINO) PIPERIDIN-1-YL]-2-METHOXYPHENYL}AMINO)-1-METHYL-4,5-DIHYDRO-1H-PYRAZOLO[4- ,3-h]QUINAZOLINE-3-CARBOXAMIDE, ITS PREPARATION, AND FORMULATIONS CONTAINING IT | 2020-08-06 |
20200246340 | USE OF COENZYME FACTOR FOR ACTIVATION OF ATP PRODUCTION IN CELL | 2020-08-06 |
20200246341 | PHARMACEUTICAL COMPOSITION FOR TREATING THYROID CANCER COMPRISING TYROSINE KINASE ACTIVITY INHIBITOR AS ACTIVE INGREDIENT | 2020-08-06 |
20200246342 | CONCENTRATED METHOTREXATE SOLUTIONS | 2020-08-06 |
20200246343 | COMPOSITION FOR TREATMENT OF MUSCULAR DISORDERS | 2020-08-06 |
20200246344 | MITOFLAVOSCINS: TARGETING FLAVIN-CONTAINING ENZYMES ELIMINATES CANCER STEM CELLS (CSCS) BY INHIBITING MITOCHONDRIAL RESPIRATION | 2020-08-06 |
20200246345 | ALDEHYDE CONJUGATES AND USES THEREOF | 2020-08-06 |
20200246346 | COMBINATION THERAPY | 2020-08-06 |
20200246347 | Substituted Pyrrolopyridine-Derivatives | 2020-08-06 |
20200246348 | METHODS, SYSTEM, AND KIT FOR MONITORING, DIAGNOSING, AND TREATING IMPULSIVE AGGRESSION | 2020-08-06 |
20200246349 | RET INHIBITOR | 2020-08-06 |
20200246350 | PHENOTHIAZINE DIAMINIUM SALTS AND THEIR USE | 2020-08-06 |
20200246351 | COMBINATIONS AND USES AND TREATMENTS THEREOF | 2020-08-06 |
20200246352 | Vanadyl and vanadate for use in reducing stress-induced metabolic derangement | 2020-08-06 |
20200246353 | TRANSDERMAL AND/OR TOPICAL DELIVERY SYSTEM COMPRISING CLOBAZAM | 2020-08-06 |
20200246354 | ADJUVANT THERAPY FOR USE IN PROSTATE CANCER TREATMENT | 2020-08-06 |
20200246355 | Glucocorticoid Particles and Their Use | 2020-08-06 |
20200246356 | NEUROSTEROIDS AND ENANTIOMERS THEREOF FOR THE PREVENTION AND TREATMENT OF NEURODEGENERATIVE CONDITIONS | 2020-08-06 |
20200246357 | Use of Nor-Ursodeoxycholic Acid for Reducing Liver Fat | 2020-08-06 |
20200246358 | METHODS OF PREVENTING PLATELET ACTIVATION | 2020-08-06 |
20200246359 | COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC CONDITIONS | 2020-08-06 |
20200246360 | USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLOGICAL DISEASES | 2020-08-06 |
20200246361 | Compositions and Methods for Treatment of Fibrosis | 2020-08-06 |
20200246362 | Arginase Inhibitors as Therapeutics | 2020-08-06 |
20200246363 | FORMULATIONS FOR THE DELIVERY OF AUTOPHAGY STIMULATING TREHALOSE | 2020-08-06 |
20200246364 | MEDICAL APPLICATION OF COMPOSITION OF FRUCTOSE-1,6-BISPHOSPHATE AND BLOOD CONCENTRATION STABILIZER THEREOF | 2020-08-06 |
20200246365 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS INHIBITORS OF RAN GTPASE | 2020-08-06 |
20200246366 | BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES | 2020-08-06 |
20200246367 | FLAVONOID COMPOSITIONS AND USES THEREOF | 2020-08-06 |
20200246368 | Compositions Containing Decitabine, 5Azacytidine and Tetrahydrouridine and Uses Thereof | 2020-08-06 |
20200246369 | ANTISENSE OLIGONUCLEOTIDE AND COMPOSITION FOR PREVENTION OR TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE IA | 2020-08-06 |
20200246370 | Methods and Compositions for RNAi Mediated Inhibition of Gene Expression in Mammals | 2020-08-06 |
20200246371 | MALTOSYL-ISOMALTOOLIGOSACCHARIDES | 2020-08-06 |
20200246372 | METHODS OF TREATING MOTOR NEURON DISEASES | 2020-08-06 |
20200246373 | ENZYMATICALLY HYDROLYSED PECTIC POLYSACCHARIDES FOR TREATING OR PREVENTING INFECTIONS | 2020-08-06 |
20200246374 | TREATMENT OF BONE MARROW PATHOLOGIES WITH POLYSUFATED POLYSACCHARIDES | 2020-08-06 |
20200246375 | INJECTABLE MONOPHASE HYDROGELS | 2020-08-06 |
20200246376 | HYDROGEN BASED COMPOSITIONS | 2020-08-06 |
20200246377 | COMPOSITION FOR USE IN THE PREVENTION AND IN THE TREATMENT OF IRON DEFICIENCY | 2020-08-06 |
20200246378 | COMPOSITIONS AND METHODS FOR DENTAL MINERALIZATION | 2020-08-06 |
20200246379 | COMPOSITIONS OF FUNCTIONAL MITOCHONDRIA AND USES THEREOF | 2020-08-06 |
20200246380 | Pharmaceutical Composition for Preventing or Treating Autoimmune Disease, and Method for Producing Same | 2020-08-06 |
20200246381 | CHIMERIC ANTIGEN RECEPTOR (CAR) BINDING TO BCMA, AND USES THEREOF | 2020-08-06 |
20200246382 | CHIMERIC ANTIGEN AND T CELL RECEPTORS AND METHODS OF USE | 2020-08-06 |
20200246383 | COMPOUNDS BINDING TO FIBROBLAST ACTIVATION PROTEIN ALPHA AND METHODS OF MAKING AND USING | 2020-08-06 |
20200246384 | PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY | 2020-08-06 |
20200246385 | MICRO-ORGANOIDS, AND METHODS OF MAKING AND USING THE SAME | 2020-08-06 |
20200246386 | METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS | 2020-08-06 |
20200246387 | MESENCHYMAL STEM CELLS AND USES THEREFOR | 2020-08-06 |
20200246388 | Method For Enhancing Expression Of Insulin Like Growth Factor 1 Receptor In Mesenchymal Stem Cell, Method For Obtaining Mesenchymal Stem Cell, And Method For Treating Brain Tissue Damage | 2020-08-06 |
20200246389 | METHODS FOR OBTAINING CARDIOMYOGENIC PRECURSOR CELLS | 2020-08-06 |
20200246390 | MULTIPOTENT ADULT PROJENITOR CELLS FOR TREATMENT OF ICH | 2020-08-06 |
20200246391 | THERAPEUTIC COMBINATION COMPRISING A PULMONARY SURFACTANT AND A STEROID FOR THE TREATMENT OF EVOLVING BPD | 2020-08-06 |
20200246392 | COMPOSITION FOR TREATMENT OF THYROID ASSOCIATED OPHTHALMOPATHY, COMPRISING MESENCHYMAL STEM CELL | 2020-08-06 |
20200246393 | TUMOR SUPPRESSION USING HUMAN PLACENTA-DERIVED INTERMEDIATE NATURAL KILLER (PINK) CELLS IN COMBINATION WITH AN ANTIBODY | 2020-08-06 |
20200246394 | Bacteria Engineered to Reduce Hyperphenylalaninemia | 2020-08-06 |
20200246395 | COMPOSITIONS OF MICROBIOTA AND METHODS RELATED THERETO | 2020-08-06 |
20200246396 | INHIBITION OF COLONIC GROUP 3 INNATE LYMPHOID CELLS | 2020-08-06 |
20200246397 | ANTIMICROBIAL THERAPY | 2020-08-06 |
20200246398 | THERAPEUTIC MICROBIOTA FOR THE TREATMENT AND/OR PREVENTION OF FOOD ALLERGY | 2020-08-06 |
20200246399 | COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS | 2020-08-06 |
20200246400 | GROWTH-STIMULATING LACTOBACILLUS STRAINS | 2020-08-06 |
20200246401 | PHARMACEUTICAL COMPOSITION COMPRISING A PROBIOTIC AND PREBIOTIC TO PREVENT ACQUISITION OF OR TREAT DRUG RESISTANT INFECTIONS | 2020-08-06 |
20200246402 | PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF PROBIOTIC AND PREBIOTIC TO TREAT STUNTING | 2020-08-06 |
20200246403 | YEAST EXTRACT HAVING DIABETES PREVENTION EFFECT | 2020-08-06 |
20200246404 | FORMULATIONS | 2020-08-06 |
20200246405 | PHARMACEUTICAL COMPOSITION AND METHOD OF MANUFACTURING | 2020-08-06 |
20200246406 | PHARMACEUTICAL COMPOSITION AND METHOD OF MANUFACTURING | 2020-08-06 |
20200246407 | COMPOSITION CONTAINING SAPONINS OF PANAX GINSENG AS ACTIVE INGREDIENT | 2020-08-06 |
20200246408 | COMPOSITIONS FOR RELIEVING PAIN WITH MALKANGNI OIL AND CYPRIOL OIL AS ACTIVE INGREDIENTS AND METHOD OF TOPICAL ADMINISTRATION OF THE SAME | 2020-08-06 |
20200246409 | PHARMACEUTICAL COMPOSITION FOR USE IN INCREASING HAIR, MODIFYING SCALP OR SKIN, HEALING A WOUND, PROMOTING OSTEOGENESIS, OR MODIFYING HAIR | 2020-08-06 |
20200246410 | BAUHINIA EXTRACT AND USES THEREOF | 2020-08-06 |
20200246411 | ANTI-DIARRHOEAL HERBAL COMPOSITIONS | 2020-08-06 |
20200246412 | PHYTOCOMPLEXES EXHIBITING MULTIPLE, SYNERGISTIC ANTIOXIDANT ACTIVITIES USEFUL IN FOODS, DIETARY SUPPLEMENTS, COSMETICS AND PHARMACEUTICAL PREPARATIONS | 2020-08-06 |
20200246413 | COMPOSITION FOR TREATING FINE DUST-CAUSED SKIN CELL DAMAGE, COMPRISING PRUNUS MUME FLOWER EXTRACT | 2020-08-06 |
20200246414 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CONSTIPATION AND OTHER AILMENTS OF THE GASTROINTESTINAL SYSTEM | 2020-08-06 |
20200246415 | COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND DEVICES AND METHODS OF PRODUCTION AND USE THEREOF | 2020-08-06 |
20200246416 | METHODS FOR TREATING SEVERE ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R INHIBITOR | 2020-08-06 |
20200246417 | ANGIO-3 FOR TREATMENT OF RETINAL ANGIOGENIC DISEASES | 2020-08-06 |
20200246418 | METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 | 2020-08-06 |
20200246419 | CYCLIC PROSAPOSIN PEPTIDES AND USES THEREOF | 2020-08-06 |
20200246420 | pHLIP.RTM. peptide-mediated epitope tethering at cell surfaces | 2020-08-06 |
20200246421 | Compositions, Methods and Uses for Treating Post-Traumatic Stress Disorder | 2020-08-06 |
20200246422 | Methods and Compositions for Improving Quality of Life and Increasing Activity in Aging and Chronically Ill Mammals | 2020-08-06 |
20200246423 | STABLE AQUEOUS FORMULATIONS OF AFLIBERCEPT | 2020-08-06 |